Hansa Biopharma AB (publ)

HNSBF · OTC
Analyze with AI
$2.91+$0.00 (+0%)
At close:Dec 16, 2025, 9:00 PM UTC
P/E TTM-3.7
P/B TTM-4.22
P/S TTM13.26
Dividend Yield0%
EPS-$0.98
Beta1.818
Valuation
PEG Ratio1.46
FCF Yield-23.68%
EV / EBITDA-6.34
More On Valuation »
Quality
ROIC-115.77%
Gross Margin59.47%
Cash Conv. Ratio1.04
More On Quality »
Growth
Revenue 3Y CAGR3.50%
FCF Growth10.71%
More On Growth »
Safety
Net Debt / EBITDA-1.40
Interest Coverage-3.44
More On Safety »
Efficiency
Inventory Turnover20.51
Cash Conv. Cycle123.25
More On Efficiency »

Hansa Biopharma AB (publ) (HNSBF) stock FAQs

Quick answers sourced from live Financial Modeling Prep fundamentals and AlphaPilot portfolio guidance.

What is Hansa Biopharma AB (publ) (HNSBF) stock price today?

As of Dec 16, 2025, 9:00 PM UTC, Hansa Biopharma AB (publ) (HNSBF) stock is trading at $2.91. The stock price is quoted in USD and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date HNSBF stock quotes for informed trading decisions.

What is Hansa Biopharma AB (publ)'s market capitalization?

Hansa Biopharma AB (publ) (HNSBF) has a market capitalization of approximately $246.6M. Market cap is calculated by multiplying the current share price by the total number of outstanding shares. This valuation metric helps investors compare Hansa Biopharma AB (publ)'s size relative to other companies in the USD market. The market cap figure updates automatically as the HNSBF stock price changes.

What is the 52-week range for Hansa Biopharma AB (publ) stock?

Hansa Biopharma AB (publ) (HNSBF) stock has traded in a 52-week range of $2.73 — $4.58. The 52-week range shows the highest and lowest prices at which HNSBF traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current Hansa Biopharma AB (publ) stock price to this range provides context for recent price action.

How much trading volume does Hansa Biopharma AB (publ) stock have?

Hansa Biopharma AB (publ) (HNSBF) stock recently traded approximately 150 shares. Trading volume indicates market liquidity and investor interest in HNSBF. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting Hansa Biopharma AB (publ) stock.

Does Hansa Biopharma AB (publ) pay dividends to shareholders?

Yes, Hansa Biopharma AB (publ) (HNSBF) currently offers a dividend yield of approximately 0%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate Hansa Biopharma AB (publ) stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.

What is Hansa Biopharma AB (publ)'s intraday price range?

Today, Hansa Biopharma AB (publ) (HNSBF) stock has traded in a range of $2.91 — $2.93. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring HNSBF's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.

Where does AlphaPilot get Hansa Biopharma AB (publ) stock data?

AlphaPilot sources real-time HNSBF stock quotes, fundamental financial data, and historical price charts for Hansa Biopharma AB (publ) from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The Hansa Biopharma AB (publ) stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of HNSBF stock performance.